Pharma News

A non-invasive procedure has been used by scientists to help people with paralysis to voluntarily move their legs. The study is reported in the Journal of Neurotrauma.

Black men are twice as likely to suffer from prostate cancer than compared to white counterparts.

Until now genetic aberrations have been seen as the main cause of almost all cancers.  A new study says ovarian cancer cannot can solely occur as a result of protein imbalances within the cells.  The study was published in the journal Oncogene.

ANI Pharmaceuticals, Inc., an integrated specialty pharmaceutical company, announced that its ANDA collaboration partner Sofgen,  received approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Nimodipine 30mg capsules. ANI and Sofgen expect to begin shipping to customers this year.

MedPlus has recently launched e-commerce service ‘Click. Pick & Save’ in Delhi and NCR area. With this launch, the service is available in all the top metro areas of the country except Mumbai.

Researchers have now identified that absence of a brain chemical can lead to hyperactivity and sleeplessness. The findings were found in the Neuron. These findings could help researchers to develop new drugs that promote better sleep, or control hyperactivity in people with the medical condition mania.

A new drug, called PF-04449913, which was found promising for treating blood cancer is now in phase II clinical trials. The study appeared online in the The Lancet Hematology.

A Training Workshop was conducted on 5th Aug, 2015 by Ms. Monisha Mullick of Goldfield Fragrances, Mumbai in collaboration with Mikasa Cosmetics & Nirma University, Ahmedabad.

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval of Merck's investigational antibiotic Zerbaxa (ceftolozane and tazobactam). This is used for the treatment of the complicated intra-abdominal infections, acute pyelonephritis, and complicated urinary tract infections in adults.